Suppr超能文献

新型突变导致甲状腺激素抵抗揭示亮氨酸341在甲状腺激素受体β中的作用

Role of Leucine 341 in Thyroid Hormone Receptor Beta Revealed by a Novel Mutation Causing Thyroid Hormone Resistance.

作者信息

Wejaphikul Karn, Groeneweg Stefan, Dejkhamron Prapai, Unachak Kevalee, Visser W Edward, Chatterjee V Krishna, Visser Theo J, Meima Marcel E, Peeters Robin P

机构信息

1 Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus Medical Center Rotterdam, The Netherlands.

2 Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

出版信息

Thyroid. 2018 Nov 27. doi: 10.1089/thy.2018.0146.

Abstract

Leucine 341 has been predicted from crystal structure as an important residue for thyroid hormone receptor beta (TRβ) function, but this has never been confirmed in functional studies. Here, a novel p.L341V mutation as a cause of resistance to TRβ is described, suggesting an important role for L341 in TRβ function. In silico and in vitro studies confirmed that substituting L341 with valine and other non-polar amino acids impairs sensitivity of TRβ for triiodothyronine to various degrees, depending on their side-chain size and orientation.

摘要

根据晶体结构预测,亮氨酸341是甲状腺激素受体β(TRβ)功能的重要残基,但这从未在功能研究中得到证实。本文描述了一种导致TRβ抵抗的新型p.L341V突变,提示L341在TRβ功能中起重要作用。计算机模拟和体外研究证实,用缬氨酸和其他非极性氨基酸取代L341会不同程度地损害TRβ对三碘甲状腺原氨酸的敏感性,这取决于它们的侧链大小和取向。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验